Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Share News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.60
Bid: 1.50
Ask: 1.70
Change: -0.10 (-5.88%)
Spread: 0.20 (13.333%)
Open: 1.65
High: 1.65
Low: 1.60
Prev. Close: 1.70
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Chamberlin Gets GBP200,000 Funding From IQ-AI CEO Brown

Fri, 19th Feb 2021 17:39

Chamberlin PLC - castings and engineering firm - Receives GBP200,000 of new funding from real estate investor and IQ-AI Ltd Chief Executive Trevor Brown. Brown, who is also CEO of Braveheart Investment Group PLC has been issued with GBP200,000 notes as the funding was advanced through an unsecured convertible loan note instrument. Subject to shareholder approval, these notes will convert automatically into 3.3 million new shares at 6 pence each, a 14% discount to the January 3 closing middle market price before suspension. The shares will represent an approximately 29.5% stake in Chamberlin's enlarged share capital.

Upon conversion, conditional on the passing of resolutions at its March 8 general meeting, Chamberlin has agreed to appoint Brown as a non-executive director, where he "has agreed to explore with the board all potential options of further funding to help stabilise the short-to-medium term working capital requirements of the company."

Following this transaction, and further fundraising, possibly including additional equity fundraising, Chamberlin will be in a position to publish its annual accounts for its financial year ended March 2020 on a going concern basis as well as its interim results for the six months ended September 30. This should, in turn, result in its share suspension being lifted.

The note conversion is conditional on shareholder approval for re-organising Chamberlin's share capital and the granting of necessary share allotment authorities to directors. This is because authorities granted July 2019 has expired, meaning not only the conversion but also any future equity fundraising are dependent on shareholder approval.

Chamberlin notes that if it cannot obtain additional funds it "will be unable to continue trading as a going concern" and that if shareholders do not pass the needed resolution then it "is expected to be unable to comply with one or more financial covenants that are in place under the terms of its existing facilities with its lending banks."

"If the company is unable to reach agreement on alternative arrangements with its lending banks and other creditors (including HM Revenue & Customs), then this could lead to enforcement action over all or part of the group's assets including executing a disposal of such assets. In the event that the resolutions are not passed, the directors would likely seek to place the company into some form of insolvency proceeding, or a creditor may take action to enforce or initiate an insolvency proceeding. Any such proceeding would be likely to result in little or no value for shareholders. Accordingly it is important that Shareholders vote in favour of all of the resolutions so that the conversion may proceed and all funding options are available to the board," says Chamberlin.

Current stock price: 7.00 pence

By Anna Farley; annafarley@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
27 Jun 2023 11:47

IN BRIEF: IQ-AI notes Gallium Moltate studies on tumour growth

IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC's two new pre-clinical studies show oral Gallium Maltolate inhibits brain tumour growth in children. Says the results are consistent with previous work conducted in the Schmainda Lab at the Medical College of Wisconsin. This follows IB's application for Orphan Drug Designation to the US Food & Drug Administration back in April for the use of GaM in pediatric brain tumours. Notes application is currently under review.

Read more
23 May 2023 16:12

TRADING UPDATES: Harworth optimistic on 2027; Plexus extends agreement

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
16 May 2023 15:53

UK shareholder meetings calendar - next 7 days

Wednesday 17 May 
Alpha Group International PLCAGM
Aptitude Software Group PLCAGM
Aston Martin Lagonda Global Holdings PLCAGM
Baillie Gifford Shin Nippon PLCAGM
Cenkos Securities PLCGM re all-share merger between Cenkos and finnCap
Coats Group PLCAGM
Coca-Cola HBC AGAGM
Computacenter PLCAGM
Conduit Holdings LtdAGM
EKF Diagnostics Holdings PLCAGM
finnCap Group PLCGM re all-share merger between Cenkos and finnCap
Gamma Communications PLCAGM
Georgia Capital PLCAGM
Greggs PLCAGM
HgCapital Trust PLCAGM
Highcroft Investments PLCAGM
Impact Healthcare REIT PLCAGM
Just Eat Takeaway.com NVAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Mpac Group PLCAGM
Savills PLCAGM
Tortilla Mexican Grill PLCAGM
TP ICAP Group PLCAGM
WPP PLCAGM
Thursday 18 May 
Ascential PLCAGM
Asimilar Group PLCAGM
Belvoir Group PLCAGM
Bridgepoint Group PLCAGM
Capital LtdAGM
Central Asia Metals PLCAGM
Ceres Power Holdings PLCAGM
ConvaTec Group PLCAGM
Diaceutics PLCAGM
Digital 9 Infrastructure PLCAGM
Energean PLCAGM
European Assets Trust PLCAGM
Fintel PLCAGM
Genuit Group PLCAGM
Inchcape PLCAGM
Invesco Asia Trust PLCAGM
JPMorgan American Investment Trust PLCAGM
Legal & General Group PLCAGM
Lloyds Banking Group PLCAGM
Merchants Trust PLCAGM
Michelmersh Brick Holdings PLCAGM
musicMagpie PLCAGM
Next PLCAGM
Network International Holdings PLCAGM
NIOX Group PLCAGM
PensionBee Group PLCAGM
Public Policy Holding Co IncAGM
Quilter PLCAGM
Riverstone Energy LtdAGM
Safestyle UK PLCAGM
Science Group PLCAGM
Secure Trust Bank PLCAGM
Smart Metering Systems PLCAGM
Somero Enterprises IncAGM
St James's Place PLCAGM
Tyman PLCAGM
Unite Group PLCAGM
Vesuvius PLCAGM
Vistry Group PLCAGM
Yu Group PLCAGM
Friday 19 May 
Bank of Georgia Group PLCAGM
Permanent TSB Group Holdings PLCAGM
Sancus Lending Group LtdAGM
Monday 22 May 
Blackrock Latin American Investment Trust PLCAGM
Crossword Cybersecurity PLCAGM
Judges Scientific PLCAGM
Stelrad Group PLCAGM
Venture Life Group PLCAGM
Tuesday 23 May 
888 Holdings PLCAGM
Access Intelligence PLCAGM
Arix Bioscience PLCAGM
Bank of Ireland Group PLCAGM
Big Technologies PLCAGM
Bigblu Broadband PLCAGM
Centamin PLCAGM
CT Private Equity Trust PLCAGM
Empresaria Group PLCAGM
Epwin Group PLCAGM
Forterra PLCAGM
Fresnillo PLCAGM
Fulcrum Utility Services LtdGM re issue of conversion shares
Gresham Technologies PLCAGM
Harworth Group PLCAGM
Hilton Food Group PLCAGM
hVIVO PLCAGM
HydrogenOne Capital Growth PLCAGM
IQ-AI LtdAGM
JTC PLCAGM
K3 Business Technology Group PLCAGM
Pebble Group PLCAGM
Portmeirion Group PLCAGM
PPHE Hotel Group LtdAGM
Restaurant Group PLCAGM
Shell PLCAGM
Sherborne Investors (Guernsey) C LtdAGM
TMT Investments PLCAGM
Triple Point Income VCT PLCAGM
Triple Point Social Housing REIT PLCAGM
Trustpilot Group PLCAGM
Twentyfour Income Fund LtdAGM
Wickes Group PLCAGM
Xeros Technology Group PLCAGM
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
26 Apr 2023 14:43

EARNINGS SUMMARY: Third Point Investors NAV per share drops by quarter

(Alliance News) - The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Read more
28 Feb 2023 19:40

TRADING UPDATES: AIQ revenue soars; Mobius Investment net assets drop

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
11 Jan 2023 09:30

CORRECT: Getech signs deal; AfriTin confirms name change

(Corrects that Zenith Energy is based in Canada, not in Scotland.)

Read more
10 Jan 2023 21:34

TRADING UPDATES: Getech signs deal; AfriTin confirms name change

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
16 Aug 2022 14:39

IN BRIEF: IQ-AI shares plummet on widening interim loss

IQ-AI Ltd - Jersey-based medical services firm - Posts larger interim pretax loss due to increased administrative costs. Pretax loss in the half-year to June 30 widens to GBP330,584 from GBP207,135 a year ago. Revenue climbs 7.2% to GBP255,609 from GBP238,488. However, revenue growth is offset by administrative costs increasing by 34% to GBP583,346 from GBP436,247.

Read more
11 Jul 2022 13:34

IN BRIEF: IQ-AI launches IB Clinic on Bayer Calantic platform

IQ-AI Ltd - Jersey-based medical services firm - Says its medical imaging analysis software, IB Clinic, is now available via the newly launched Bayer Calantic platform. The distribution partnership continues its strategy of making IB Clinic accessible to healthcare providers through widespread networks, the company adds.

Read more
31 May 2022 13:26

IN BRIEF: IQ-AI shares rise with submission of application to US FDA

IQ-AI Ltd - Jersey-based medical services firm - Says subsidiary Imaging Biometrics LLC submits 510(k) application to US Food & Drug Administration for IB Zero G, an artificial intelligence software that eliminates the need for gadolinium-based contrast agents in routine magnetic imagining exams. "The FDA 510(k) submission is the first step in potentially transforming the global gadolinium-based contrast agent market and introducing a paradigm shift in radiology departments," company says.

Read more
31 May 2022 10:44

SMALL-CAP WINNERS & LOSERS: IQ-AI's IB Zero G moves closer to approval

(Alliance News) - The following stocks are the leading risers and fallers among London Main Market small-caps on Tuesday.

Read more
3 May 2022 16:36

IQ-AI imaging technology gets vote of confidence in US study

(Alliance News) - IQ-AI Ltd unit Imaging Biometrics on Tuesday said a study concluded its imaging technology was successful in identifying tumours.

Read more
28 Apr 2022 19:25

TRADING UPDATES: Impellam's first quarter beats pre-virus levels

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
9 Mar 2022 20:30

IN BRIEF: IQ-AI opens oral gallium malotate trial for enrolment

IQ-AI Ltd - Jersey-based medical services firm - Says phase one clinical trial for oral gallium maltolate is open for enrolment. Patient recruitment in the trial is underway and potential volunteers that meet the inclusion criteria have already been identified, it notes. Phase one dose escalation study is designed to determine the optimal dose of GaM that can be administered safely. It is the first-in-human clinical trial for an oral form of GaM to be used in patients with high-grade brain tumours, it adds.

Read more
11 Nov 2021 19:43

TRADING UPDATES: Beximco profit rises; Tremor buoyant as sales rise

TRADING UPDATES: Beximco profit rises; Tremor buoyant as sales rise

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.